Managing pharmaceutical regulation in Germany: overview and economic assessment
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Berlin
Techn. Univ.
2004
|
| Series: | Diskussionspapier / Wirtschaftswissenschaftliche Dokumentation, Technische Universität Berlin
2004,6 |
| Subjects: | |
| Physical Description: | 47 S. graph. Darst. |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV043815736 | ||
| 003 | DE-604 | ||
| 005 | 20240201 | ||
| 007 | t | ||
| 008 | 161007s2004 d||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)249376411 | ||
| 035 | |a (DE-599)BVBBV043815736 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-11 | ||
| 084 | |a QB 910 |0 (DE-625)141231: |2 rvk | ||
| 084 | |a QR 420 |0 (DE-625)142032: |2 rvk | ||
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a 330 |2 sdnb | ||
| 100 | 1 | |a Schreyögg, Jonas |d 1976- |e Verfasser |0 (DE-588)123827604 |4 aut | |
| 245 | 1 | 0 | |a Managing pharmaceutical regulation in Germany |b overview and economic assessment |c Jonas Schreyögg, Klaus-Dirk Henke, Reinhard Busse |
| 264 | 1 | |a Berlin |b Techn. Univ. |c 2004 | |
| 300 | |a 47 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Diskussionspapier / Wirtschaftswissenschaftliche Dokumentation, Technische Universität Berlin |v 2004,6 | |
| 650 | 4 | |a Arzneimittelmarkt / Regulierung / Gesundheitskosten / Wirtschaftspolitische Wirkungsanalyse / Deutschland | |
| 650 | 0 | 7 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Regulierung |0 (DE-588)4201190-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |2 gnd |9 rswk-swf |
| 651 | 7 | |a Deutschland |0 (DE-588)4011882-4 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Deutschland |0 (DE-588)4011882-4 |D g |
| 689 | 0 | 1 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 0 | 2 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
| 689 | 0 | 3 | |a Regulierung |0 (DE-588)4201190-5 |D s |
| 689 | 0 | |5 DE-188 | |
| 700 | 1 | |a Henke, Klaus-Dirk |d 1942- |e Verfasser |0 (DE-588)121038165 |4 aut | |
| 700 | 1 | |a Busse, Reinhard |d 1963- |e Verfasser |0 (DE-588)132798662 |4 aut | |
| 810 | 2 | |a Wirtschaftswissenschaftliche Dokumentation, Technische Universität Berlin |t Diskussionspapier |v 2004,6 |w (DE-604)BV008027612 |9 2004,6 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029226864 | ||
Record in the Search Index
| _version_ | 1804176667626700800 |
|---|---|
| any_adam_object | |
| author | Schreyögg, Jonas 1976- Henke, Klaus-Dirk 1942- Busse, Reinhard 1963- |
| author_GND | (DE-588)123827604 (DE-588)121038165 (DE-588)132798662 |
| author_facet | Schreyögg, Jonas 1976- Henke, Klaus-Dirk 1942- Busse, Reinhard 1963- |
| author_role | aut aut aut |
| author_sort | Schreyögg, Jonas 1976- |
| author_variant | j s js k d h kdh r b rb |
| building | Verbundindex |
| bvnumber | BV043815736 |
| classification_rvk | QB 910 QR 420 QR 525 |
| ctrlnum | (OCoLC)249376411 (DE-599)BVBBV043815736 |
| discipline | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01985nam a2200469 cb4500</leader><controlfield tag="001">BV043815736</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240201 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">161007s2004 d||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)249376411</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043815736</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-11</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QB 910</subfield><subfield code="0">(DE-625)141231:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 420</subfield><subfield code="0">(DE-625)142032:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">330</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schreyögg, Jonas</subfield><subfield code="d">1976-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)123827604</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Managing pharmaceutical regulation in Germany</subfield><subfield code="b">overview and economic assessment</subfield><subfield code="c">Jonas Schreyögg, Klaus-Dirk Henke, Reinhard Busse</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin</subfield><subfield code="b">Techn. Univ.</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">47 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Diskussionspapier / Wirtschaftswissenschaftliche Dokumentation, Technische Universität Berlin</subfield><subfield code="v">2004,6</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arzneimittelmarkt / Regulierung / Gesundheitskosten / Wirtschaftspolitische Wirkungsanalyse / Deutschland</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Regulierung</subfield><subfield code="0">(DE-588)4201190-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Regulierung</subfield><subfield code="0">(DE-588)4201190-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Henke, Klaus-Dirk</subfield><subfield code="d">1942-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)121038165</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Busse, Reinhard</subfield><subfield code="d">1963-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)132798662</subfield><subfield code="4">aut</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Wirtschaftswissenschaftliche Dokumentation, Technische Universität Berlin</subfield><subfield code="t">Diskussionspapier</subfield><subfield code="v">2004,6</subfield><subfield code="w">(DE-604)BV008027612</subfield><subfield code="9">2004,6</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029226864</subfield></datafield></record></collection> |
| geographic | Deutschland (DE-588)4011882-4 gnd |
| geographic_facet | Deutschland |
| id | DE-604.BV043815736 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T07:35:50Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029226864 |
| oclc_num | 249376411 |
| open_access_boolean | |
| owner | DE-11 |
| owner_facet | DE-11 |
| physical | 47 S. graph. Darst. |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Techn. Univ. |
| record_format | marc |
| series2 | Diskussionspapier / Wirtschaftswissenschaftliche Dokumentation, Technische Universität Berlin |
| spelling | Schreyögg, Jonas 1976- Verfasser (DE-588)123827604 aut Managing pharmaceutical regulation in Germany overview and economic assessment Jonas Schreyögg, Klaus-Dirk Henke, Reinhard Busse Berlin Techn. Univ. 2004 47 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Diskussionspapier / Wirtschaftswissenschaftliche Dokumentation, Technische Universität Berlin 2004,6 Arzneimittelmarkt / Regulierung / Gesundheitskosten / Wirtschaftspolitische Wirkungsanalyse / Deutschland Arzneimittelmarkt (DE-588)4003131-7 gnd rswk-swf Regulierung (DE-588)4201190-5 gnd rswk-swf Gesundheitspolitik (DE-588)4113743-7 gnd rswk-swf Deutschland (DE-588)4011882-4 gnd rswk-swf Deutschland (DE-588)4011882-4 g Gesundheitspolitik (DE-588)4113743-7 s Arzneimittelmarkt (DE-588)4003131-7 s Regulierung (DE-588)4201190-5 s DE-188 Henke, Klaus-Dirk 1942- Verfasser (DE-588)121038165 aut Busse, Reinhard 1963- Verfasser (DE-588)132798662 aut Wirtschaftswissenschaftliche Dokumentation, Technische Universität Berlin Diskussionspapier 2004,6 (DE-604)BV008027612 2004,6 |
| spellingShingle | Schreyögg, Jonas 1976- Henke, Klaus-Dirk 1942- Busse, Reinhard 1963- Managing pharmaceutical regulation in Germany overview and economic assessment Arzneimittelmarkt / Regulierung / Gesundheitskosten / Wirtschaftspolitische Wirkungsanalyse / Deutschland Arzneimittelmarkt (DE-588)4003131-7 gnd Regulierung (DE-588)4201190-5 gnd Gesundheitspolitik (DE-588)4113743-7 gnd |
| subject_GND | (DE-588)4003131-7 (DE-588)4201190-5 (DE-588)4113743-7 (DE-588)4011882-4 |
| title | Managing pharmaceutical regulation in Germany overview and economic assessment |
| title_auth | Managing pharmaceutical regulation in Germany overview and economic assessment |
| title_exact_search | Managing pharmaceutical regulation in Germany overview and economic assessment |
| title_full | Managing pharmaceutical regulation in Germany overview and economic assessment Jonas Schreyögg, Klaus-Dirk Henke, Reinhard Busse |
| title_fullStr | Managing pharmaceutical regulation in Germany overview and economic assessment Jonas Schreyögg, Klaus-Dirk Henke, Reinhard Busse |
| title_full_unstemmed | Managing pharmaceutical regulation in Germany overview and economic assessment Jonas Schreyögg, Klaus-Dirk Henke, Reinhard Busse |
| title_short | Managing pharmaceutical regulation in Germany |
| title_sort | managing pharmaceutical regulation in germany overview and economic assessment |
| title_sub | overview and economic assessment |
| topic | Arzneimittelmarkt / Regulierung / Gesundheitskosten / Wirtschaftspolitische Wirkungsanalyse / Deutschland Arzneimittelmarkt (DE-588)4003131-7 gnd Regulierung (DE-588)4201190-5 gnd Gesundheitspolitik (DE-588)4113743-7 gnd |
| topic_facet | Arzneimittelmarkt / Regulierung / Gesundheitskosten / Wirtschaftspolitische Wirkungsanalyse / Deutschland Arzneimittelmarkt Regulierung Gesundheitspolitik Deutschland |
| volume_link | (DE-604)BV008027612 |
| work_keys_str_mv | AT schreyoggjonas managingpharmaceuticalregulationingermanyoverviewandeconomicassessment AT henkeklausdirk managingpharmaceuticalregulationingermanyoverviewandeconomicassessment AT bussereinhard managingpharmaceuticalregulationingermanyoverviewandeconomicassessment |